MFC-XG

Description

Indication

MFC-XG is an antibiotic used to treat a variety of bacterial infections such as community-acquired pneumonia, bronchitis, sinusitis, skin and soft tissue infections, and intra-abdominal infections.

Pharmacology

MFC-XG belongs to the class of antibiotics known as fluoroquinolones. It works by inhibiting the activity of enzymes involved in bacterial DNA replication and synthesis, which prevents the bacteria from multiplying and leads to their death.

Dosage & Administration

The dosage and administration of moxifloxacin may vary depending on the condition being treated, patient age, weight, kidney function, and other factors. It is available in tablet and injection form.

Tablet

The recommended adult dose for most infections is 400 mg once a day for 5-21 days.

Injection

The recommended adult dose for most infections is 400 mg once a day for 5-14 days.

How long does it take to work?

MFC-XG typically starts working within a few days after starting treatment. However, it is important to complete the full course of treatment as prescribed by your doctor, even if you start feeling better.

Side effects

Common side effects of moxifloxacin may include:

• Nausea and vomiting
• Diarrhea
• Headache
• Dizziness
• Insomnia
• Rash
• Abdominal pain

Some rare but serious side effects may also occur, such as:

• Tendinitis or tendon rupture
• Peripheral neuropathy
• Central nervous system effects, such as seizures or confusion
• Hypersensitivity reactions

Warnings

Before using moxifloxacin, tell your doctor if you have a history of any medical conditions, especially kidney disease, liver disease, or seizures. MFC-XG may interact with other medications, so inform your doctor about any prescription, non-prescription, or herbal products you are currently taking.

Precautions

MFC-XG may cause dizziness or lightheadedness, so use caution when driving or operating heavy machinery until you know how the medication affects you. It is also important to avoid excessive exposure to sunlight or artificial UV light while taking moxifloxacin, as it may increase your risk of sunburn.

Pregnancy and lactation use

MFC-XG should only be used during pregnancy if the benefits outweigh the risks to the fetus. It is not recommended for use during breastfeeding, as it may pass into breast milk and harm a nursing baby.

Acute overdose

In case of an overdose, seek emergency medical attention or contact the Poison Help line at 1-800-222-1222. Symptoms of an overdose may include seizures, hallucinations, confusion, and irregular heartbeats.

Food Interactions:

MFC-XG should be taken at least 4 hours before or 8 hours after antacids, sucralfate, metal cations, or multivitamins that contain zinc or iron, as they can interfere with its absorption.

Interactions with Other Medicines:

MFC-XG can interact with several medications, including:

• Anticoagulants (e.g., warfarin)
• Corticosteroids (e.g., prednisone)
• Nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen)
• Theophylline (used to treat asthma)
• Some drugs used to treat heart rhythm problems, such as amiodarone or quinidine
• Some drugs used to treat psychiatric conditions, such as fluoxetine or tricyclic antidepressants

These interactions can lead to changes in the blood levels of these medications or moxifloxacin, increasing the risk of side effects or decreasing the effectiveness of treatment. Therefore, it is important to inform the healthcare provider about all the medications, vitamins, and herbal supplements being taken before starting moxifloxacin.

Half-Life:

The average half-life of moxifloxacin is approximately 12 hours.

Volume of Distribution:

The volume of distribution of moxifloxacin is approximately 1.7 L/kg, indicating that the drug is widely distributed in the body.

Clearance:

MFC-XG is mainly eliminated through the liver and excreted in the urine and feces. The clearance of moxifloxacin is approximately 12 L/h, indicating that the drug is eliminated relatively quickly from the body.

Contradictions:

MFC-XG should not be used in individuals who have a history of hypersensitivity to the drug or any of its components. It is also contraindicated in individuals with a history of tendon disorders related to fluoroquinolone use. The use of moxifloxacin is also contraindicated in individuals who are pregnant or breastfeeding, as well as in children under 18 years of age.

Storage Conditions:

MFC-XG should be stored at room temperature between 15°C and 30°C (59°F and 86°F). The tablets should be kept in their original container, tightly closed and protected from light and moisture. Unused solutions for injection should be discarded after 24 hours.

Here you find in details version of MFC-XG